Characteristic or classification | n (%) |
---|---|
Year of publication | |
 2011–2013 | 15 (18.3) |
 2014–2016 | 21 (25.6) |
 2017–2019 | 35 (42.7) |
 2020-present | 11 (13.4) |
Continent of origin | |
 Europe | 41 (50.0) |
 North America | 19 (23.2) |
 Asia | 12 (14.6) |
 Australia | 3 (3.7) |
 South America | 2 (2.4) |
 Other* | 5 (6.1) |
Language of publication | |
 English | 57 (69.5) |
 Dutch | 7 (8.5) |
 Finnish | 5 (6.1) |
 German | 4 (4.9) |
 Other** | 9 (11.0) |
Body system addressed by guideline | |
 Respiratory*** | 50 (61.0) |
 Urinary | 20 (24.4) |
 Skin and soft tissue (SSTI) | 12 (14.6) |
AGREE II domain scores across all guidelines | |
---|---|
Domain score | Median score (range%) |
Scope and purpose | 86.1 (38.9–100) |
Clarity of presentation | 84.8 (50.0–100) |
Rigour and development | 79.2 (11.5–100) |
Stakeholder involvement | 77.8 (16.7–100) |
Editorial independence | 70.8. (4.2–100) |
Applicability | 64.5 (20.8–91.7) |